Bisphosphonates in colorectal cancer
Limburg, P.J.; Singh, S.
Clinical Advances in Hematology and Oncology H&o 11(6): 372-374
2013
ISSN/ISBN: 1543-0790 PMID: 24472806 Document Number: 665934
Document emailed within 1 workday
Related Documents
Aaltonen, L.A.; Sankila, R.; Mecklin, J.P.; Järvinen, H.; Pukkala, E.; Peltomäki, P.; de la Chapelle, A. 1994: A novel approach to estimate the proportion of hereditary nonpolyposis colorectal cancer of total colorectal cancer burden Cancer Detection and Prevention 18(1): 57-63Vehmanen, L.; Saarto, T. 2010: Bisphosphonates and breast cancer Duodecim; Laaketieteellinen Aikakauskirja 126(10): 1229-1237
Cerea, G.; Vaghi, M.; Ardizzoia, A.; Villa, S.; Bucovec, R.; Mengo, S.; Gardani, G.; Tancini, G.; Lissoni, P. 2003: Biomodulation of cancer chemotherapy for metastatic colorectal cancer: a randomized study of weekly low-dose irinotecan alone versus irinotecan plus the oncostatic pineal hormone melatonin in metastatic colorectal cancer patients progressing on 5-fluorouracil-containing combinations Anticancer Research 23(2c): 1951-1954
Lüftner, D.; Henschke, P.; Possinger, K. 2007: Clinical value of bisphosphonates in cancer therapy Anticancer Research 27(4a): 1759-1768
Ishida, H.; Fujioka, M.; Ohsawa, T.; Takeuchi, I.; Nakada, H.; Ishizuka, N.; Yokoyama, M.; Inokuma, S.; Yamada, H.; Odaka, A.; Hoshino, T.; Murata, N.; Hashimoto, D.; Matsumoto, Y.; Miura, T. 2001: Effect of peroral doxifluridine plus hepatic arterial infusion for synchronous liver metastasis of colorectal cancer--correlation with the expression of thymidine phosphorylase and dihydropyrimidine dehydrogenase in primary colorectal cancer lesions Gan to Kagaku Ryoho. Cancer and ChemoTherapy 28(11): 1624-1627
Aft, R. 2011: Bisphosphonates in breast cancer: antitumor effects Clinical Advances in Hematology and Oncology: H&o 9(4): 292-299
Barginear, M.F.; Van Poznak, C. 2010: Bisphosphonates: do we know their role in adjuvant breast cancer treatment? Oncology 24(6): 475; 478, 480
Saad, F.; Chi, K.; Fleshner, N. 2004: The role of bisphosphonates in the management of bone metastases in prostate cancer Canadian Journal of Urology 11(5): 2376-2382
Yamada, K.; Kohno, N. 2007: Clinical study of bisphosphonates for bone metastasis in breast cancer Nihon Rinsho. Japanese Journal of Clinical Medicine 65(Suppl 9): 352-355
Beuran, M.; Chiotoroiu, A.L.; Chilie, A.; Morteanu, S.; Vartic, M.; Avram, M.; Roşu, O.; Lică, I. 2010: Stapled vs. hand-sewn colorectal anastomosis in complicated colorectal cancer--a retrospective study Chirurgia 105(5): 645-651
Vagliasindi, A.; Sivelli, R.; Gualtierotti, M.; Piccolo, D.; Bertagni, A.; Sianesi, M. 2003: Are small-size depressed-type colorectal neoplasias really the expression of a early stage of colorectal cancer. Apropos of a clinical case Tumori 89(4 Suppl): 155-158
Kanczuga-Koda, L.; Koda, M.; Sulkowski, S.; Wincewicz, A.; Zalewski, B.; Sulkowska, M. 2010: Gradual loss of functional gap junction within progression of colorectal cancer -- a shift from membranous CX32 and CX43 expression to cytoplasmic pattern during colorectal carcinogenesis In Vivo 24(1): 101-107
Zou, Y.-f.; Cai, Z.-r.; Chen, Y.-f.; Rong, Y.-m.; Wu, X.-r.; Yuan, R.-x.; He, X.-s.; Wu, X.-j.; Lan, P. 2013: Comparison of local immune microenvironment between liver-metastasis colorectal cancer and non-liver-metastasis colorectal cancer Zhonghua Wei Chang Wai Ke Za Zhi 16(6): 547-551
Kozuszko, B.; Skrzydlewski, Z.; Sulkowska, M.; Snarska, J.; Kozłowski, M.; Skrzydlewska, E.; Zalewski, B. 2001: Cancer procoagulant activity in cases of esophageal, stomach and colorectal cancer considering progression degree and histological type of cancer Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 11(63): 218-220
Gil-Ad, I.; Zolokov, A.; Lomnitski, L.; Taler, M.; Bar, M.; Luria, D.; Ram, E.; Weizman, A. 2008: Evaluation of the potential anti-cancer activity of the antidepressant sertraline in human colon cancer cell lines and in colorectal cancer-xenografted mice International Journal of Oncology 33(2): 277-286
Greene, P.; Mays, G.; Kim, K.; Hager, B.; Goldsmith, G.; Bursac, Z.; Carter, D.; Duke, K.; Mehta, P.; Tillman, R.Henry. 2009: Colorectal cancer screening in Arkansas: implications for cancer prevention in primary care Journal of the Arkansas Medical Society 106(3): 66-68
Khalil, S.; Ceccarelli, F. 2009: Colorectal cancer after breast cancer: magnitude of risk in clinical practice and in the literature Tumori 95(1): 28-31
Takahashi, K.; Hiramatsu, K.; Kawakita, M.; Mori, T.; Yamaguchi, T.; Matsumoto, H.; Miyamoto, H.; Tamamori, Y. 2004: The significance of urine di-acetyl spermine level as a cancer marker for colorectal cancer Rinsho Byori. Japanese Journal of Clinical Pathology 52(4): 332-335
Zhang, X-dong.; Shen, L.; Li, Y.; Li, J.; Yang, B-qin.; Jin, M-lin. 2003: The evaluation of LFH or LFPH in the treatment of advanced cancer of gastric cardia and colorectal cancer Zhonghua Zhong Liu Za Zhi 25(3): 289-291
Toyokawa, A.; Tsujimura, T.; Hamabe, Y.; Sato, S.; Mukubou, H.; Wakahara, T.; Kaji, M.; Tsukamoto, T.; Wakita, K.; Onishi, N.; Ishida, T.; Watanabe, A.; Fujiwara, H.; Mukai, H. 2005: Clinical study of ambulatory patient cancer chemotherapy for advanced colorectal cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 32(13): 2087-2090